BFM
KYNB

Boothbay Fund Management’s Kyntra Bio KYNB Stock Holding History

Boothbay Fund Management’s Portfolio KYNB Stock Details KYNB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-1,526
Closed -$103K – 1842
2023
Q2 		$103K Buy
+1,526
New +$631K ﹤0.01% 1613

Other funds holding KYNB

Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Jacobs Levy Equity Management
Jacobs Levy Equity Management Florham Park, New Jersey $23.8B AUM 25.4% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Boothbay Fund Management's KYNB Position: Q3 2023 in Review

Boothbay Fund Management sold out of Kyntra Bio (KYNB) in Q3 2023, closing a stake of 1,526 shares — an estimated $103K sold.

Boothbay Fund Management first reported a position in KYNB in Q2 2023 and held it in 1 quarter. The position peaked at $103K in Q2 2023. 110 funds tracked by Wall St. Rank hold KYNB as of Q3 2023.

  • Boothbay Fund Management reported no remaining Kyntra Bio position as of Q3 2023 after selling out during the quarter.
  • Boothbay Fund Management sold 1,526 Kyntra Bio shares in Q3 2023, an estimated $103K.
  • Boothbay Fund Management first reported a position in Kyntra Bio in Q2 2023 and held it in 1 quarter.
  • Boothbay Fund Management's Kyntra Bio position peaked at $103K in Q2 2023.
  • 110 funds tracked by Wall St. Rank held Kyntra Bio as of Q3 2023.

Based on Boothbay Fund Management's 13F filing for Q3 2023, filed 14 Nov 2023.